%D9%85%D8%AA%D9%84%D8%A7%D8%B2%D9%85%D8%A9_%D8%A7%D9%86%D8%AD%D9%84%D8%A7%D9%84_%D8%A7%D9%84%D8%AF%D9%85_%D8%A7%D9%84%D9%8A%D9%88%D8%B1%D9%8A%D9%85%D9%8A%D8%A9S%C3%ADndrome_hemoliticour%C3%A8micaCategory:Hemolytic-uremic_syndromeH%C3%A6molytisk-ur%C3%A6misk_syndromH%C3%A4molytisch-ur%C3%A4misches_SyndromHemolytic%E2%80%93uremic_syndromeS%C3%ADndrome_ur%C3%A9mico_hemol%C3%ADtico%D9%86%D8%B4%D8%A7%D9%86%DA%AF%D8%A7%D9%86_%D9%87%D9%85%D9%88%D9%84%DB%8C%D8%AA%DB%8C%DA%A9_%D8%A7%D9%88%D8%B1%D9%85%DB%8C%DA%A9Syndrome_h%C3%A9molytique_et_ur%C3%A9mique%D5%80%D5%A5%D5%B4%D5%B8%D5%AC%D5%AB%D5%BF%D5%AB%D5%AF-%D5%B8%D6%82%D6%80%D5%A5%D5%B4%D5%AB%D5%AF_%D5%B0%D5%A1%D5%B4%D5%A1%D5%AD%D5%BF%D5%A1%D5%B6%D5%AB%D5%B7Sindrom_uremik-hemolitikSindrome_emolitico-uremica%E6%BA%B6%E8%A1%80%E6%80%A7%E5%B0%BF%E6%AF%92%E7%97%87%E7%97%87%E5%80%99%E7%BE%A4%EC%9A%A9%ED%98%88%EC%84%B1_%EC%9A%94%EB%8F%85%EC%A6%9D%ED%9B%84%EA%B5%B0H%C3%A4molytescht-ur%C3%A4mescht_SyndromH%C3%A4molyytsch-ur%C3%A4%C3%A4msch_SyndromHemolytisch-uremisch_syndroomHemolytisk_uremisk_syndromHemolytisk-uremisk_syndrom%E0%AC%B9%E0%AD%87%E0%AC%AE%E0%AD%8B%E0%AC%B2%E0%AC%BF%E0%AC%9F%E0%AC%BF%E0%AC%95-%E0%AD%9F%E0%AD%81%E0%AC%B0%E0%AC%BF%E0%AC%AE%E0%AC%BF%E0%AC%95_%E0%AC%B8%E0%AC%BF%E0%AC%A3%E0%AD%8D%E0%AC%A1%E0%AD%8D%E0%AC%B0%E0%AD%8B%E0%AC%AEZesp%C3%B3%C5%82_hemolityczno-mocznicowyS%C3%ADndrome_hemol%C3%ADtico-ur%C3%AAmicaSindromul_hemolitic-uremicHemolyticko-uremick%C3%BD_syndr%C3%B3m%D0%A5%D0%B5%D0%BC%D0%BE%D0%BB%D0%B8%D1%82%D0%B8%D1%87%D0%BA%D0%B8_%D1%83%D1%80%D0%B5%D0%BC%D0%B8%D1%98%D1%81%D0%BA%D0%B8_%D1%81%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BCHemolytiskt_uremiskt_syndrom%E0%AE%9A%E0%AE%BF%E0%AE%B5%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AE%A3%E0%AF%81%E0%AE%9A%E0%AF%8D%E0%AE%9A%E0%AE%BF%E0%AE%A4%E0%AF%88%E0%AE%B5%E0%AF%81_-_%E0%AE%9A%E0%AE%BF%E0%AE%B1%E0%AF%81%E0%AE%A8%E0%AF%80%E0%AE%B0%E0%AE%95%E0%AE%9A%E0%AF%8D%E0%AE%9A%E0%AF%86%E0%AE%AF%E0%AE%B2%E0%AE%BF%E0%AE%B4%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AF%81%E0%AE%95%E0%AF%8D_%E0%AE%95%E0%AF%82%E0%AE%9F%E0%AF%8D%E0%AE%9F%E0%AE%B1%E0%AE%BF%E0%AE%95%E0%AF%81%E0%AE%B1%E0%AE%BF%E0%B8%81%E0%B8%A5%E0%B8%B8%E0%B9%88%E0%B8%A1%E0%B8%AD%E0%B8%B2%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B9%80%E0%B8%A1%E0%B9%87%E0%B8%94%E0%B9%80%E0%B8%A5%E0%B8%B7%E0%B8%AD%E0%B8%94%E0%B9%81%E0%B8%94%E0%B8%87%E0%B9%81%E0%B8%95%E0%B8%81-%E0%B8%A2%E0%B8%B9%E0%B8%A3%E0%B8%B5%E0%B9%80%E0%B8%A1%E0%B8%B5%E0%B8%A2Hemolitik_%C3%BCremik_sendromQ162266%E6%BA%B6%E8%A1%80%E6%80%A7%E5%B0%BF%E6%AF%92%E7%BB%BC%E5%90%88%E5%BE%81
about
TTP and aHUS in Complicated PregnanciesErythropoietin in Hemolytic Uremic SyndromeOutcame of Cases With Hemolytic Uremic Syndrome Attending Assiut University Child HospitalEculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant RecipientsStudy of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic ColitisAtypical Hemolytic-Uremic Syndrome (aHUS) RegistryaHUS Observational Long Term Follow-UpEculizumab Use in the Postpartum Period for the Treatment of Pregnancy Associated aHUS: A Case SeriesOutbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4A Study of an Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic SyndromeA Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)Haemolytic Uraemic Syndrome in Childhood: Clinical, Cognitive and Psychological AspectsThe Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS PatientsRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordThe Plasma Large-Volume Exchange RCTAn Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic SyndromeSafety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney DiseaseAn Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic SyndromeOpen Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUSOpen Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUSOpen Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUSOpen Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)International Registry and Biorepository for TMA(Thrombotic Microangiopathy)rVA576 (Coversin) Long Term Safety and Efficacy Surveillance StudyUsefulness of a Diagnostic Algorithm to Diagnose Thrombotic Microangiopathies in PregnancyShiga Toxin Producing Escherichia Coli (STEC) Volume ExpansionStudy Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUSComplement Inhibition in aHUS Dialysis PatientsRituximab in Patients With Relapsed or Refractory TTP-HUSThe Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury)Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic SyndromeStudy of ALXN1210 in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic SyndromeEculizumab to Cemdisiran Switch in aHUSSingle Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)Study of 'Vascular Competence' Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and AdultsThe Role of Microparticles as a BiomarkerEval. of Potential Predictors of Disease Progression in Patients With aHUS Including Genetics, Biomarkers and Treatment
P1050
P2175
Complement factor H and the hemolytic uremic syndromeInterventions for preventing diarrhea-associated hemolytic uremic syndrome: systematic reviewSubtyping of STEC by MLVA in ArgentinaHemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature.Streptococcus pneumoniae-associated hemolytic uremic syndrome.Complement in glomerular injury.Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome.Complement and the atypical hemolytic uremic syndrome in children.Exploiting the nephrotoxic effects of venom from the sea anemone, Phyllodiscus semoni, to create a hemolytic uremic syndrome model in the ratShigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies.Enterohemorrhagic E. coli (EHEC) pathogenesis.The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreakHaemolytic-uraemic syndrome as a sequela of diarrhoeal disease.Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.Complement therapy in atypical haemolytic uraemic syndrome (aHUS).New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndromeHow I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndromeGemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.Altered renovascular resistance after spontaneous recovery from hemolytic uremic syndrome.Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coliA case of hemolytic uremic syndrome associated with Epstein-Barr virus infection.Protection against Shiga ToxinsShiga Toxin Therapeutics: Beyond Neutralization.Microvesicle Involvement in Shiga Toxin-Associated Infection.Role of polymorphonuclear leukocytes in the pathophysiology of typical hemolytic uremic syndrome.Atypical hemolytic uremic syndromeErythropoietin in Hemolytic Uremic SyndromeManagement of STEC Gastroenteritis: Is There a Role for Probiotics?Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a andHaemolytic uremic syndrome: diagnosis and management
P921
Q61907296-107B42E7-A57E-4110-9AE2-B19BF0F37FB0Q62030789-2F7D90A2-B5F6-4AD0-B789-239460C53311Q62054199-E0A49399-6850-4C06-BFD3-514CEE859BC1Q62817228-B03C66A1-8F4E-472D-8B56-A5BCEB040761Q63316445-56BE207E-DF54-4167-A46B-B52031E123E3Q63319884-C9ED7C08-2BA1-4399-85D2-DB59B3704A92Q63319887-561DBF47-BCAE-4492-ABE7-21F395B2D2A0Q63396967-4F81C4B0-8097-49CB-8752-70EBD569E884Q63806806-AA1D03CF-5416-4A79-A240-0839C5929F04Q63811565-CB8B4673-531A-4C22-87F7-61757A77E55EQ63836470-B954ABD1-332E-421F-A837-064E4F4531B1Q63837426-549B5675-91A7-412E-9E89-8E327DDCDDA7Q63838036-BAD29F85-C7AE-4F3B-879D-D46A31BC0543Q63838769-717F5E93-E2FE-464A-8AA6-84270CDE78F8Q64634650-175391ED-B83C-493D-89D5-1FF3E13C7923Q64648152-2A1F9765-6523-4ED9-A0B3-5018C6BD386FQ64652372-7304E9D9-C0A9-4EF8-9B71-AD113726DFABQ64660496-7AFA52C3-1444-4D49-A883-1FABECE49E62Q64673745-2089698A-3AA1-46F2-9371-ACC89B50354EQ64678132-BB243E30-E9E8-416E-B8FB-CBFE0AA2A223Q64681091-37154324-D188-4E33-9A90-BEB93AF6450DQ64681129-928FD91E-434F-4582-9541-B52F8CBA6C7BQ64681138-66020524-8ECD-41D1-B8C9-2B9B66B6CAD6Q64694331-A59748AC-25D8-4674-9568-CD151D04EE38Q64724937-3054BF45-56B4-42BA-B616-02E0E6D8C338Q64792972-FBABC5B5-A94F-4DA5-A20A-D9C85EE1936CQ64795105-095DD7BA-DB31-4BD1-8422-A7270F1BD77BQ64819142-74D70C32-953D-4D0C-9D8D-B9271F7F37BEQ65317682-4FA6D80F-E84C-48AB-8073-C4FE78642558Q65346310-AD5CF7E6-E520-4C0C-8872-F6C02FC3140CQ65472581-CE43B6C5-6DFC-40D2-8D7F-F97D0D3EE5ECQ65475037-266EA5BC-8C2B-47B3-AD16-AA8518B019E9Q66041489-7300E46D-6A71-4B7A-A39D-F0D6896F4529Q66044465-1B352A47-1AE3-42AD-A45C-0877BE6881FEQ66061902-3FC4D7D9-48C7-4289-8D4D-6E689DC3673CQ66062688-D7557F47-76A9-431D-A862-8FE88B477ACDQ66078864-7AFE9D00-B9A4-4EA4-B0AE-A1EBC2F3819AQ66082221-076582CA-DAC3-4EF9-8171-9DFE47FE66D2Q66411150-DD1A90D9-68C1-4060-9A2F-580C1E959F7EQ67129650-D30909F1-66C8-4590-9F2B-268EA787347D
P1050
Q24676234-3F4A59F8-301B-4287-A628-9CDF238F8CBBQ26861109-BE5AE9F2-BD47-4913-B50B-766307F0FC58Q27693203-A1B06F77-7270-4BE6-AC40-A72A7A343302Q30249618-9D4AA737-0B53-4F2A-826D-7E910A04EA5EQ33375543-5CFFAEB1-E53D-4015-B816-DC9124A37DB1Q33376840-FEA88101-395C-45B9-85C0-C0737A08D0FBQ33379683-3E619811-E94E-4760-85B3-0881EF458EE0Q33380163-2135354A-95E9-4E82-915A-961069737E20Q33402623-5FF4240D-C704-47EC-B863-10A1E803838DQ33402784-356AA9F9-D07F-40C9-B5FE-1B40C160EC3BQ33402961-0E129E07-3612-486E-9EE4-F97A79ED594CQ33402995-7CCE8D41-0519-4912-A3E0-5CABBF0302FFQ33403923-D57F46D9-AACC-4C3E-9F7F-AE0EA0402025Q33404640-7498B608-B73A-4C9F-94B5-9F11BAFF861BQ33408733-D7D87CED-A9B0-49CC-8B88-C15E2F50EED1Q33409878-973E19FC-D547-4199-BD9F-BF565AC916A0Q33412445-C02E37F4-2E15-497D-B23F-436C992F7491Q33413284-2A7135D3-C81E-4C1A-82B8-DE99A0CF586CQ33488951-D12B5E84-A79A-4E09-BF62-6BDC433CCD99Q33500218-5A65B464-F7DE-4942-9C6B-707616E4ECA2Q33503585-04618DA6-393E-437A-8EF7-058B7E1DE4E2Q39122055-19A2E5A0-9308-42DB-9D38-A6FB665E99DFQ41669177-11CE9385-D5C9-4A2F-B8E1-BB9179D49DDBQ47127903-B04391B8-46B2-471A-88C6-0ED162D042BCQ55184390-3FE938B2-C5C0-45FB-8A82-EB5D8D2294E2Q56591965-26BE7408-3FF1-499B-8C2D-4BB61CA609A1Q62030789-5FA4B962-7610-4F11-9137-BBFFC52D79BBQ64039312-3459BBE1-AEB4-47D5-896F-F1ACC5BB528BQ64055279-F0C0D61E-674C-4CF0-9CE5-886DD90A2A99Q90618941-37745E55-4E3F-44FA-8C09-4100A5F9ACEB
P921
description
Human disease
@en
Krankheit
@de
malattia umana
@it
مرض يصيب الإنسان
@ar
ମାନବ ରୋଗ
@or
name
Hemolitik üremik sendrom
@tr
Hemolitički uremijski sindrom
@sr-el
Hemolyticko-uremický syndróm
@sk
Hemolytisch-uremisch syndroom
@nl
Hämolytescht-urämescht Syndrom
@lb
Hämolyytsch-uräämsch Syndrom
@nds
Hæmolytisk-uræmisk syndrom
@da
Sindrom uremik-hemolitik
@id
Zespół hemolityczno-mocznicowy
@pl
hemolytic-uremic syndrome
@en
type
label
Hemolitik üremik sendrom
@tr
Hemolitički uremijski sindrom
@sr-el
Hemolyticko-uremický syndróm
@sk
Hemolytisch-uremisch syndroom
@nl
Hämolytescht-urämescht Syndrom
@lb
Hämolyytsch-uräämsch Syndrom
@nds
Hæmolytisk-uræmisk syndrom
@da
Sindrom uremik-hemolitik
@id
Zespół hemolityczno-mocznicowy
@pl
hemolytic-uremic syndrome
@en
altLabel
Gasser-Syndrom
@de
Gasser-Syndrom
@nds
HU-Syndrom
@de
HUS
@en
HUS
@it
HUS
@ja
HUS
@lb
HUS
@nds
HUS
@nn
Hemolytic-uremic syndrome
@th
prefLabel
Hemolitik üremik sendrom
@tr
Hemolitički uremijski sindrom
@sr-el
Hemolyticko-uremický syndróm
@sk
Hemolytisch-uremisch syndroom
@nl
Hämolytescht-urämescht Syndrom
@lb
Hämolyytsch-uräämsch Syndrom
@nds
Hæmolytisk-uræmisk syndrom
@da
Sindrom uremik-hemolitik
@id
Zespół hemolityczno-mocznicowy
@pl
hemolytic-uremic syndrome
@en
P2888
P492
P672
P486
P6366
P646
P1245
P1417
topic/hemolytic-uremic-syndrome